HPLC method for the determination of nimodipme in rat plasma, brain tissues and cerebrospinal fluid

wang zhengrong,zhang qizhi,jiang xinguo,su lina

DOI: https://doi.org/10.3969/j.issn.1007-4406.2004.04.008

2004-01-01

Abstract:AIM: To develop a reversed phase HPLC method for the determination of nimodipine (NM) in rat plasma, brain tissues and cerebrospinal fluid (CSF) . METHODS: NM in plasma and brain tissue was extracted with n-hexane/diethylether (1 : 1) and NM in CSF was measured directly. Chromatographic separation was achieved at ambient temperature on a DiamonsilTM C18(200 mm×4.6 mm, 5 μm) analytical column. The mobile phase consisted of acetoni trile-0.05 mol·L-1 ammonium acetate in a ratio of 60:40 (V/V) for the plasma and brain tissue samples, and 65:35 for CSF analysis. The flow rate was 1 mL·min-1. UV detection was set at 358nm. NM was administered intravenously (iv) to rats at a dose of 2 mg·kg-1, and the concentrations of NM in three kinds of biological samples were analyzed by the analytical procedures currently established. RESULTS: The linear range of NM was 20-1000μg·L-1, 25-3 500 ng· g-1 and 10-150 μg·L-1 and the detection limits were 15 μg·L-1, 15 ng·g-1 and 8 μg·L-1 for plasma, brain tissue and CSF samples, respectively. Method recovery was 98.71%-103.86%, inter-and intra-day variations were less than 6%. The extraction recoveries of NM from plasma and tissue homogenates were more than 80% . Plasma concentration data after iv administration was fitted to a two-compartment model. Brain NM concentrations reached peak level at 2 min post dose and similar NM concentrations were found in different brain tissues. However, the uptake of NM into CSF was low. CONCLUSION: The method can be used to study the pharmacokinetics of NM in rats.